None listed
Conditions
Brief summary
This prospective study 0f 20 patients.In both the groups Bilateral TAP catheters will be placed using an ultrasound guided approach post-operatively with the bolus dose of 20 ml of 0.5% Ropivacaine bilaterally. In post anaesthetic care unit (PACU) an infusion of Ropicavaine 0.2% will be administered @ 8ml/hr for 2 days in the Continuous group. Whereas in Intermittent group only bolus doses 20ml 0.2% ropivacaine will be administered by the Acute pain service personnell every 8 hrly for 48 hrs. Patients in both groups will be provided with Paracetamol 1 gram 4 times a day (orally or IV) and a Fentanyl PCA device (bolus 10 to 40 mcg; lockout time 5 min; no back-ground infusion) as part of a multimodal analgesic approach. The following parameters will be registered: Numerical Rating Scores for Pain (NRS-P; 0-10) at rest and on coughing in PACU at 0 and I hour and in the postoperative ward at 24 hrs, 48 hrs. Fentanyl use in PACU and postoperative ward on day 1 & day 2. Procedure related: material costs and other issues will be noted. Any rescue medication used. A 4 point ‘Likert’-scale will be used on day 2 and during a follow-up telephone call at one month to assess patient satisfaction with the analgesic technique used. discharge time and cost analysis will be assessed. All results will be recorded on a data collection sheet in a prospective fashion and subsequently entered in a protected database
Interventions
In the continous group under ultrasound guidance TAP block performed and catheter inserted,thru the catheter the anaesthetist boluses ropivacaine 0.5% 20ml on each side, followed by ropivacaine 0.2% infusion @ 8ml/hr each side in recovery room till 48hrs. whereas in Intermittent group with same technique and same bolus dose as other gp but subsequent bolus of 0.2% ropivacaine 20ml each side delivered by pain service team at 8hours intervel till 48hrs.
Patients in both groups will be provided wit
In the continous group under ultrasound guidance TAP block performed and catheter inserted,thru the catheter the anaesthetist boluses ropivacaine 0.5% 20ml on each side, followed by ropivacaine 0.2% infusion @ 8ml/hr each side in recovery room till 48hrs. whereas in Intermittent group with same technique and same bolus dose as other gp but subsequent bolus of 0.2% ropivacaine 20ml each side delivered by pain service team at 8hours intervel till 48hrs. Patients in both groups will be provided with Paracetamol 1 gram 4 times a day (orally or IV) and a Fentanyl PCA device (bolus 10 to 40 mcg; lockout time 5 min; no back-ground infusion) as part of a multimodal analgesic approach
Sponsors
The Queen Elizabeth hospital
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject, Investigator)
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
Inclusion Criteria: Elective abdominal surgery Between 18 and 85 years of age ASA less then 4 Adequate English language skills
Exclusion criteria
Emergency surgery Allergy to local anaesthetic Pregnancy On regular opioid medication prior to surgery Mental handicap or psychiatric condition precluding adequate communication
Outcome results
None listed